Fernwood投资管理公司增加了对BridgeBio Pharma的股份,目前拥有261,735股。 Fernwood Investment Management increased its stake in BridgeBio Pharma, now owning 261,735 shares.

Fernwood投资管理公司将BridgeBio Pharma的股权提高了2.4%,现在拥有261,735股。 Fernwood Investment Management raised its stake in BridgeBio Pharma by 2.4%, now owning 261,735 shares. 机构投资者持有公司99.85%的股份,市场上限为47.9亿美元。 Institutional investors hold 99.85% of the company, which has a market cap of $4.79 billion. 最近,内部人士出售了超过580万股。 Recently, insiders sold over 5.8 million shares. 在最后一个季度,BridgeBio公司报告每股净损失0.39美元,比预期损失1.0美元好,收入比上一年增加32.1%。 In the latest quarter, BridgeBio reported a net loss of $0.39 per share, better than the expected loss of $1.00, with revenue up 32.1% year-over-year.